Europe Radiodermatitis Market Size & Outlook, 2023-2030
Europe radiodermatitis market, 2018-2030 (US$M)
Related Markets
Europe radiodermatitis market highlights
- The Europe radiodermatitis market generated a revenue of USD 78.4 million in 2023.
- The market is expected to grow at a CAGR of 3.5% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2023.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 78.4 million |
| Market revenue in 2030 | USD 99.4 million |
| Growth rate | 3.5% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, Europe region accounted for 18.4% of the global radiodermatitis market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 260.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 71.81% in 2023. Horizon Databook has segmented the Europe radiodermatitis market based on oral, topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
Regional radiodermatitis market for Europe is expected to show growth over the forecast period owing to the presence of well-established healthcare system and establishment of various nongovernmental organizations such as European Radiation burns Association (EBA) is expected to further increase the growth of radiodermatitis market.
Moreover, this organization conducts educational courses for multidisciplinary teams, surgeons and other healthcare professionals.The major players in this region are undertaking strategic steps such as merger & acquisitions, partnership agreements, etc.
In February 2016, Acelity L.P. Inc. entered in a partnership with Mediq to enhance the distribution network of its advanced radiodermatitis and regenerative medicines in Denmark, Norway, Finland and Sweden. All these factors are contributing towards the growth of radiodermatitis market.
Reasons to subscribe to Europe radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe radiodermatitis market , including forecasts for subscribers. This continent databook contains high-level insights into Europe radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe radiodermatitis market size, by country, 2018-2030 (US$M)
Europe Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
